Big drop after top line result announcements Print E-mail
By Jaime Tera   
Monday, 12 October 2009 07:17

This specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies will be hosting a conference call today after seeing a big drop following some disappointing news.

DepoMed, Inc.(NASDAQ:DEPO) whose shares closed at $6.36 +0.55 (9.47%) on friday has pre-market shares trading considerably lower at $4.30 -2.06 (-32.39%) after the company announced top line results from the BREEZE I and II Phase III clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes. A full report on the findings can be read here.

Just last week, the company announced top-line results from a Phase 3 clinical trial demonstrating DM-1796 (also referred to as gabapentin ER) achieved a statistically significant reduction in pain associated with postherpetic neuralgia (PHN) versus placebo using the baseline observation carried forward (BOCF) method required by FDA.

Depomed has announced a conference call to discusse the top-line results and during the call the management team sounded much more optimistic than expected and they said that despite the results, they remains hopeful about the program and plans to discuss the results with U.S. regulators.




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter